13D/13G Filings - 4D Molecular Therapeutics Inc. (FDMT)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2, Next
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-02-14
5:01 pm
Purchase
2023-12-31 13G 4D Molecular Therapeutics, Inc.
FDMT
RA Capital Management, L.P. 4,163,211
9.700%
1,373,490increase
(+49.23%)
Filing
History
2024-02-14
4:37 pm
Purchase
2023-12-31 13G 4D Molecular Therapeutics, Inc.
FDMT
Kirn David 2,033,069
4.700%
10,571increase
(+0.52%)
Filing
History
2024-02-14
09:56 am
Unchanged
2023-12-31 13G 4D Molecular Therapeutics, Inc.
FDMT
BIOTECHNOLOGY VALUE FUND L P 4,007,413
9.400%
0
(Unchanged)
Filing
History
2024-02-14
08:43 am
Sale
2023-12-31 13G 4D Molecular Therapeutics, Inc.
FDMT
Deep Track Capital, LP 2,284,372
5.340%
-372,529decrease
(-14.02%)
Filing
History
2024-02-13
10:56 am
Purchase
2023-12-31 13G 4D Molecular Therapeutics, Inc.
FDMT
JANUS HENDERSON GROUP PLC
JHG
3,093,296
7.200%
1,627,029increase
(+110.96%)
Filing
History
2024-01-25
4:59 pm
Purchase
2023-12-31 13G 4D Molecular Therapeutics, Inc.
FDMT
BLACKROCK INC
BLK
3,464,587
8.100%
955,955increase
(+38.11%)
Filing
History
2024-01-08
4:15 pm
Sale
2024-01-04 13G 4D Molecular Therapeutics, Inc.
FDMT
VIKING GLOBAL INVESTORS LP 4,247,914
9.900%
-540,000decrease
(-11.28%)
Filing
History
2024-01-08
4:05 pm
Purchase
2023-12-31 13G 4D Molecular Therapeutics, Inc.
FDMT
VIKING GLOBAL INVESTORS LP 4,787,914
11.200%
850,000increase
(+21.59%)
Filing
History
2023-06-05
4:31 pm
Purchase
2023-05-25 13G 4D Molecular Therapeutics, Inc.
FDMT
RA Capital Management, L.P. 2,789,721
6.700%
2,789,721increase
(New Position)
Filing
History
2023-05-15
4:17 pm
Purchase
2023-05-05 13G 4D Molecular Therapeutics, Inc.
FDMT
Venrock Healthcare Capital Partners III L.P. 2,887,517
8.700%
2,887,517increase
(New Position)
Filing
History
2023-02-14
08:32 am
Purchase
2022-12-31 13G 4D Molecular Therapeutics, Inc.
FDMT
Deep Track Capital, LP 2,656,901
8.200%
756,901increase
(+39.84%)
Filing
History
2023-02-09
09:07 am
Sale
2022-12-31 13G 4D Molecular Therapeutics, Inc.
FDMT
JANUS HENDERSON GROUP PLC
JHG
1,466,267
4.500%
-181,656decrease
(-11.02%)
Filing
History
2023-02-08
4:15 pm
Sale
2022-12-31 13G 4D Molecular Therapeutics, Inc.
FDMT
Kirn David 2,022,498
6.200%
-11,877decrease
(-0.58%)
Filing
History
2023-01-31
1:58 pm
Purchase
2022-12-31 13G 4D Molecular Therapeutics, Inc.
FDMT
BLACKROCK INC
BLK
2,508,632
7.700%
420,950increase
(+20.16%)
Filing
History
2022-06-21
4:53 pm
Purchase
2022-06-16 13G 4D Molecular Therapeutics, Inc.
FDMT
BIOTECHNOLOGY VALUE FUND L P 4,007,413
12.400%
2,001,551increase
(+99.79%)
Filing
History
2022-02-14
5:02 pm
Unchanged
2021-12-31 13G 4D Molecular Therapeutics, Inc.
FDMT
VIKING GLOBAL INVESTORS LP 3,937,914
12.300%
0
(Unchanged)
Filing
History
2022-02-14
4:33 pm
Purchase
2021-12-31 13G 4D Molecular Therapeutics, Inc.
FDMT
Kirn David 2,034,375
6.300%
34,375increase
(+1.72%)
Filing
History
2022-02-14
4:32 pm
Sale
2021-12-31 13G 4D Molecular Therapeutics, Inc.
FDMT
SCHAFFER DAVID 901,215
2.800%
-1,098,785decrease
(-54.94%)
Filing
History
2022-02-14
08:56 am
Purchase
2021-12-31 13G 4D Molecular Therapeutics, Inc.
FDMT
Deep Track Capital, LP 1,900,000
5.910%
100,000increase
(+5.56%)
Filing
History
2022-02-11
3:54 pm
Sale
2021-12-31 13G 4D Molecular Therapeutics, Inc.
FDMT
PFIZER INC
PFE
341,658
1.060%
-1,325,000decrease
(-79.50%)
Filing
History
Goto Prev, 0, 1, 2, Next